Schizophrenia Drugs Market will Register Significant Gain | homify
Back to Ideabooks

Schizophrenia Drugs Market will Register Significant Gain

ankit pittewar ankit pittewar
Edit
Add photo

The increasing prevalence of chronic and mental disorder is a key factor expected to enable growth in the 

global 

schizophrenia drugs market size

, says Fortune Business Insights in a report, titled “Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026.” The global schizophrenia drugs market was valued at USD 6.75 Billion in 2018 and is projected to reach USD 9.48 Billion by 2026, exhibiting a CAGR of 4.3% during the forecast period.


For more information in the analysis of this report, visit: 

https://www.fortunebusinessinsights.com/industry-reports/schizophrenia-drugs-market-101531


Key Segmentation of Schizophrenia Drugs Market:

Schizophrenia Drugs Market Segments by Therapeutic Class

·         

Second Generation

·         

Third Generation

·         

Others

Schizophrenia Drugs Market Segments by Treatment

·         

Oral

·         

Injectable

Schizophrenia Drugs Market Segments by Distribution Channel

·         

Hospital Pharmacies

·         

Retail Pharmacies

·         

Online Pharmacies

·         

Others

By Geography

·         

North America (U.S. and Canada)

·         

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

·         

Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

·         

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)